|
Volumn 354, Issue 2, 2006, Pages 203-
|
Azithromycin versus penicillin for early syphilis [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZITHROMYCIN;
PENICILLIN G;
ANTIINFECTIVE AGENT;
BENZATHINE PENICILLIN;
BIOLOGICAL MONITORING;
BLOOD PLACENTA BARRIER;
HEALTH PROGRAM;
HUMAN;
INFECTION CONTROL;
INTRAUTERINE INFECTION;
LETTER;
PRENATAL CARE;
PRIORITY JOURNAL;
REAGIN TEST;
SCREENING;
SERODIAGNOSIS;
SYPHILIS;
TREPONEMA PALLIDUM;
ANTIBIOTIC RESISTANCE;
CONGENITAL SYPHILIS;
DRUG EFFECT;
FEMALE;
GENETICS;
NOTE;
ORAL DRUG ADMINISTRATION;
PREGNANCY;
PREGNANCY COMPLICATION;
TREATMENT FAILURE;
BRAZIL;
DEVELOPING COUNTRY;
DRUG COST;
ECONOMICS;
ADMINISTRATION, ORAL;
ANTI-BACTERIAL AGENTS;
AZITHROMYCIN;
DRUG RESISTANCE, BACTERIAL;
FEMALE;
HUMANS;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
SYPHILIS;
SYPHILIS, CONGENITAL;
TREPONEMA PALLIDUM;
PENICILLIN G, BENZATHINE;
TREATMENT FAILURE;
BRAZIL;
DEVELOPING COUNTRIES;
DRUG COSTS;
|
EID: 30444460268
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc052777 Document Type: Letter |
Times cited : (17)
|
References (4)
|